Notification for WTO and non-WTO member countries under Canada's Access to Medicines Regime
Before importing a drug or medical device through Canada's Access to Medicines Regime, countries that are members of the World Trade Organization (WTO) and developing countries that are not members of the WTO, as identified on Schedule 4 to Canada's Patent Act, are required to notify
Countries must disclose the following information to the appropriate authority when planning to use the Regime:
Developing countries that are not members of the WTO are also required to declare that
For a graphic illustration of the notification process, see the process map for Schedule 4 countries.
Report a problem or mistake on this page
- Date modified: